You are here
Disease modifying therapies
- A presentation at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016, held February 18-20 in New Orleans highlighted therapeutic strategies for stem cell-based approaches to protect and restore neurological function in patients with progressive MS. Andrew Goodman...
- Recent developments in treating MS have created the need for an updated set of best practices, according to a presentation at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers, held May 27–30 in Indianapolis. Choosing the optimal...
- Though clinicians can use a variety of factors to guide their choice of MS therapy, patient preference should weigh into the decision-making process, according to a symposium presented at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers. The conference was held May 27–30 in Indianapolis. Stephen Krieger, MD, of Mount...
Interview with Dr. Mark Freedman: Insights on Interferon-beta 1a and 1b trials and the ORATORIO phase III trialDr. Freedman discussed some highlights from his work on interferon-beta that was presented at ACTRIMS Forum 2016. Interferon-beta are important...
- Journal of Neuroimmunology, Volume 288, 15 November 2015, Pages 92-97
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosisExperimental and Molecular Pathology, Volume 99, Issue 3, December 2015, Pages 498-505
Mojtaba Farjam, Guang-Xian Zhang, Bogoljub Ciric, Abdolmohamad Rostami
Journal of the Neurological Sciences
Teriflunomide: A Once-Daily Oral Medication for the Treatment of Relapsing Forms of Multiple SclerosisClinical Therapeutics, Volume 37, Issue 10, 1 October 2015, Pages 2366–2380
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progressionImmunobiology, Volume 221, Issue 2, February 2016, Pages 193–198
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients
Katja Pavsic, Katarina Pelicon, Alenka Horvat Ledinek, Sasa Sega
Clinical Neurology and Neurosurgery, Volume 139, December 2015, Pages 35 - 40